Raphaëlle Parker

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

Cornelia L. Trimble, Matthew P. Morrow, Kimberly A. Kraynyak et al. · The Lancet · 2015 · 689 citations

Immunology, Human Papillomavirus 16, Cancer-associated Virus +17

Immunotherapy Against HPV16/18 Generates Potent T _H 1 and Cytotoxic Cellular Immune Responses

Mark L. Bagarazzi, Jian Yan, Matthew P. Morrow et al. · Science Translational Medicine · 2012 · 279 citations · Full text

Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques

Stéphanie Beq, Sandra Rozlan, David Gautier et al. · Blood · 2009 · 72 citations · Full text

TGF-β in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus

Marie‐Christine Cumont, Valérie Monceaux, Laurence Viollet et al. · Cell Death and Differentiation · 2007 · 67 citations · Full text

Rhesus Macaques, Immunodeficiencies, Medicine +12

Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus.

Dau Pc, J E Callahan, Raphaëlle Parker et al. · PubMed · 1991 · 53 citations

Immunology, Pathology, Immunophenotyping +19